Penn Cardiovascular Clinical Trials
The Penn CVI coordinates clinical research trials, and national / international registries as part of its mission to advance health
and accelerate the pace at which life-saving procedures, devices, and medications reach the public.
Contact:
Ms. Brenda Rynn
Administrative and Financial Officer, Cardiovascular Medicine Division
(215) 349-8903 / cvistudy@mail.med.upenn.edu
GenTAC - National Registry of Genetically Triggered Thoracic Aortic Aneurysms
A national registry that studies people with genetic disorders to help prevent aortic aneurysm.
IRAD - International Registry of Acute Aortic Dissections
An intenational registry that evaluates the current management and outcomes of acute aortic dissection.
Trial in the News…
CABANA Trial:
Ablation Versus Drug Therapy for Atrial Fibrillation
Penn is part of a major government-funded study, the CABANA trial, which will follow 3,000 atrial fibrillation (AF) patients for three years to see whether
the treatment strategy of left atrial catheter ablation will be superior to current state-of-the-art therapy with either rate control or rhythm control drugs
for reducing total mortality in patients with untreated or incompletely treated AF.
This study is funded by the National Heart Lung Blood Institute.
Contact:
Mary Gnap
215-349-8446
Philadelphia Inquirer feature »
Trial Details »
| 
